< Back to scientific publications

Magazine 4.3

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Authors: Pellicelli A et al

Date: May 20

Scope of interest: infectious/hepatological




You may also be interested in:

Magazine 2.24

Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid Cancer

Authors: Silvia Riondino, Girolamo Del Monte, Federica Fratangeli, Fiorella Guadagni, Mario Roselli and Patrizia Ferroni

Date: 2017

Scope of interest: Coagulation and oncology


Read details
Magazine 8.52

Clozapine-induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine’s effectiveness.

Authors: Acinni T, Frascarelli M, Ghezzi F, Panzera A, Buzzanca A, Fanella M, Di Bonaventura C, Carlone L, Girardi N, Pasquini M, Di Fabio F.

Date: 2021

Scope of interest: Psychiatric disorders/rare diseases


Read details
Magazine 7.4

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Authors: ranieri r et al

Date: Apr 17, 2023

Scope of interest: infectious diseases/penitentiary health


Read details